African clinical trial denied access to key COVID drug Paxlovid
- PMID: 35379975
- DOI: 10.1038/d41586-022-00919-5
African clinical trial denied access to key COVID drug Paxlovid
Keywords: Intellectual-property rights; Medical research; Public health; SARS-CoV-2.
Comment on
-
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.N Engl J Med. 2022 Apr 14;386(15):1397-1408. doi: 10.1056/NEJMoa2118542. Epub 2022 Feb 16. N Engl J Med. 2022. PMID: 35172054 Free PMC article. Clinical Trial.
References
-
- Hammon, J. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2118542 (2022). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous